Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NAGE Niagen Bioscience

Post-Mkt 06-23 18:17:45 EDT

3.38

-0.03

-0.88%

盘后3.43

+0.05+1.48%

17:11 EDT

High3.45	Low3.37	Vol429.53K
Open3.37	D1 Closing3.41	Amplitude2.35%
Mkt Cap270.13M	Tradable Cap173.78M	Total Shares79.92M
T/O1.46M	T/O Rate0.84%	Tradable Shares51.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":3.38,"timestamp":1782244800000,"preClose":3.41,"halted":0,"volume":429532,"hourTrading":{"tag":"盘后","latestPrice":3.43,"preClose":3.38,"latestTime":"17:11 EDT","volume":5526,"amount":18675.575657999998,"timestamp":1782249078515,"change":0.05,"changeRate":0.014793,"amplitude":0.022189},"delay":0,"changeRate":-0.008797653958944354,"floatShares":51414700,"shares":79919957,"eps":0.210015,"marketStatus":"Post-Mkt","change":-0.03,"latestTime":"06-23 18:17:45 EDT","open":3.37,"high":3.445,"low":3.365,"amount":1456213.0455176,"amplitude":0.02346,"askPrice":3.68,"askSize":100,"bidPrice":3.28,"bidSize":25,"shortable":3,"etf":0,"ttmEps":0.210015,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1782259200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":3.41,"preHourTrading":{"tag":"盘前","latestPrice":3.41,"preClose":3.41,"latestTime":"09:18 EDT","volume":598,"amount":2028.810082,"timestamp":1782220686050,"change":0,"changeRate":0,"amplitude":0.01173},"postHourTrading":{"tag":"盘后","latestPrice":3.43,"preClose":3.38,"latestTime":"17:11 EDT","volume":5526,"amount":18675.575657999998,"timestamp":1782249078515,"change":0.05,"changeRate":0.014793,"amplitude":0.022189},"volumeRatio":0.692687,"impliedVol":2.9392,"impliedVolPercentile":0.9442},"requestUrl":"/m/hq/s/NAGE/wiki","defaultTab":"wiki","newsList":[{"id":"2645021853","title":"Top Growth Companies With Strong Insider Ownership For June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2645021853","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645021853?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:05","pubTimestamp":1782126345,"startTime":"0","endTime":"0","summary":"The United States market has demonstrated robust performance, climbing 1.4% in the last week and achieving a 26% increase over the past year, with earnings projected to grow by 19% annually. In this thriving environment, growth companies with strong insider ownership can be particularly appealing as they often align management interests with those of shareholders, potentially enhancing long-term value creation.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abeo/abeona-therapeutics/news/top-growth-companies-with-strong-insider-ownership-for-june","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abeo/abeona-therapeutics/news/top-growth-companies-with-strong-insider-ownership-for-june","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4187","NAGE","ABEO","BK4183","YSS","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644771568","title":"Elite Penny Stocks With Cash Strength Backing Big Growth Stories","url":"https://stock-news.laohu8.com/highlight/detail?id=2644771568","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644771568?lang=en_us&edition=fundamental","pubTime":"2026-06-17 14:26","pubTimestamp":1781677567,"startTime":"0","endTime":"0","summary":"Penny stocks are often written off as lottery tickets, but rising global rate pressures, uneven inflation trends and mixed growth data are putting a premium on strong balance sheets and access to cash. That is where the Elite Penny Stocks screener stands out. It filters for lower priced stocks that actually look funded to pursue their growth plans, rather than relying on hope and dilution. For investors who want exposure to higher risk and higher potential ideas without guessing blindly, this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/nasdaq-grab/grab-holdings/news/elite-penny-stocks-with-cash-strength-backing-big-growth-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/nasdaq-grab/grab-holdings/news/elite-penny-stocks-with-cash-strength-backing-big-growth-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999013478.USD","BK4154","LU2125910500.SGD","SG9999013460.SGD","GRAG","BK4547","SG9999002620.SGD","SG9999001135.SGD","LU0979878070.USD","SG9999013486.USD","BK4022","CLOV","LU1242518857.USD","SG9999002604.SGD","SG9999002679.SGD","LU1242518931.SGD","LU2362540622.SGD","BK4122","NAGE","BK4183","SG9999002406.SGD","LU0532188223.SGD","LU2045819591.USD","BK4230","GRAB","LU2362541513.USD","SG9999006266.SGD","LU1839390173.USD","SGXZ58947870.SGD","LU0441851309.USD","LU0210637038.USD","LU2362541273.HKD","SG9999002414.USD","BK4121",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904962","title":"Niagen Bioscience to present at East Coast IDEAS Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904962","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904962?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:37","pubTimestamp":1780490237,"startTime":"0","endTime":"0","summary":"Niagen Bioscience management will present at the East Coast IDEAS Investor Conference on June 11, 2026, in New York.CEO Rob Fried is scheduled to present from 2:40 p.m. to 3:15 p.m. ET.CFO Ozan Pamir will attend for one-on-one meetings with institutional investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire  on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL6wB1jx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640794499","title":"Niagen Bioscience renames CERP to Niagen Research Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2640794499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640794499?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:25","pubTimestamp":1780413933,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced the official renaming of the ChromaDex External Research Program, CERP, to the Niagen Research Program, reflecti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-renames-cerp-to-niagen-research-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-renames-cerp-to-niagen-research-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162124470","title":"Niagen Bioscience Rebrands External Research Program to Strengthen NAD+ Scientific Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1162124470","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162124470?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:11","pubTimestamp":1780413111,"startTime":"0","endTime":"0","summary":"Niagen Bioscience, a global authority in the science of NAD+ (nicotinamide adenine dinucleotide), has announced the formal renaming of its widely recognized \"ChromaDex External Research Program\" to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE","NAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638660086","title":"Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638660086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638660086?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:40","pubTimestamp":1779968405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Niagen Bioscience (NAGE), Guardant Health (GH) and B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-niagen-bioscience-nage-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-niagen-bioscience-nage-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4183","BK4121","BK4585","BK4196","NAGE","BK4535","GH","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637584453","title":"BRIEF-NARB Recommends Niagen Modify/Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2637584453","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637584453?lang=en_us&edition=fundamental","pubTime":"2026-05-22 00:16","pubTimestamp":1779380214,"startTime":"0","endTime":"0","summary":"BRIEF-NARB Recommends Niagen Modify/Discontinue Certain Tru Niagen Nad+ Dietary Supplement ClaimsMay 21 (Reuters) - National Advertising Review Board:NATIONAL ADVERTISING REVIEW BOARD RECOMMENDS NIAGE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637332991","title":"National Advertising Review Board Recommends Niagen Modify or Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2637332991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637332991?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:31","pubTimestamp":1779373915,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636181718","title":"Niagen Bioscience Earnings Call Highlights Growth Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2636181718","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636181718?lang=en_us&edition=fundamental","pubTime":"2026-05-20 13:40","pubTimestamp":1779255622,"startTime":"0","endTime":"0","summary":"Niagen Bioscience, Inc. (($NAGE)) has held its Q1 earnings call. Read on for the main highlights of the call. Niagen Bioscience’s latest earnings c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-earnings-call-highlights-growth-push-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-earnings-call-highlights-growth-push-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635896510","title":"Promising Penny Stocks To Consider In May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635896510","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635896510?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:05","pubTimestamp":1778843111,"startTime":"0","endTime":"0","summary":"The United States market has shown impressive growth, with a 1.1% increase over the last week and a substantial 27% rise over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. Penny stocks, while an older term, continue to capture attention as they often represent smaller or newer companies that provide growth opportunities at lower price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ltrn/lantern-pharma/news/promising-penny-stocks-to-consider-in-may-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ltrn/lantern-pharma/news/promising-penny-stocks-to-consider-in-may-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LTRN","BK4006","BK4139","ZJK","BK4531","FINV","LU1046422090.SGD","HLP","LU0049112450.USD","VFF","III","NAGE","BK4505","LX","SPRO","BK4526","BK4166","BK4189","BK4183","BK4579","TUYA","LU1235295612.USD","BK4209","BK4121","BABB","BK4023","BK4134","BK4161","BK4509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635871123","title":"May 2026's Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635871123","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635871123?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:04","pubTimestamp":1778756692,"startTime":"0","endTime":"0","summary":"The market remained flat over the last week but is up 25% over the past year, with earnings forecast to grow by 17% annually. In light of these conditions, identifying stocks with strong financials and clear growth potential becomes crucial for investors seeking value. Although the term \"penny stocks\" may seem outdated, it still points to smaller or less-established companies that can offer significant opportunities; we've identified three such stocks that stand out for their financial...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-whwk/whitehawk-therapeutics/news/may-2026s-promising-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-whwk/whitehawk-therapeutics/news/may-2026s-promising-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","VFF","BK4139","LU1046422090.SGD","ZNOG","BK4209","WHWK","BK4213","CRCT","BK4531","ZJK","BK4539","NAGE","LU0049112450.USD","LU1235295612.USD","BK4183","BK4579","MAPS","BK4526","BK4161","BK4166","BK4509","BK4023","BK4189","BABB","CRBU","BK4121","BK4191","LX","TUYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635789270","title":"Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635789270","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635789270?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:05","pubTimestamp":1778670322,"startTime":"0","endTime":"0","summary":"The market has climbed 1.5% in the last 7 days and is up 26% over the last 12 months, with earnings forecast to grow by 17% annually. While the term 'penny stock' might seem outdated, these investments still offer potential value by focusing on smaller or newer companies with strong financials. In this article, we explore three penny stocks that demonstrate financial strength and could present opportunities for investors seeking hidden value in quality companies.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmci/treace-medical-concepts/news/spotlight-on-oramed-pharmaceuticals-and-two-other-prominent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmci/treace-medical-concepts/news/spotlight-on-oramed-pharmaceuticals-and-two-other-prominent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4189","VFF","BK4183","BK4509","BK4139","BK4531","ORMP","TMCI","MGNX","BK4082","BK4007","BABB","NAGE","ZJK","BK4166","WDH","BK4539","BK4121","BK4191","BK4134","LU1235295612.USD","BK4173","BK4579","LU0049112450.USD","LX","BK4161","BK4209","LU1046422090.SGD","CRCT","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213100","title":"Creative Global Technology Holdings And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213100","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213100?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:04","pubTimestamp":1778583898,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the U.S. market has risen by 2.6%, and in the past year, it has climbed an impressive 26%, with earnings forecasted to grow by 17% annually. In such a robust market environment, identifying stocks with solid financials becomes crucial for investors seeking potential growth opportunities. Though often considered a relic of past trading days, penny stocks still hold relevance today as they offer affordability and growth potential when backed by strong fundamentals; this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4133000-choice2-main-header/1585187156628","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4133000-choice2-main-header/1585187156628"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nyse-ufi/unifi/news/creative-global-technology-holdings-and-2-other-promising-pe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nyse-ufi/unifi/news/creative-global-technology-holdings-and-2-other-promising-pe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4173","BK4209","BK4539","PYXS","BABB","BK4140","BK4161","BK4023","BK4509","LU0049112450.USD","CGTL","ZJK","MAPS","BK4121","NAGE","BK4134","LX","LU1046422090.SGD","LU1235295612.USD","VFF","UFI","BK4139","BK4010","BK4166","WDH","BK4531","BK4183","BK4579","BK4189","CINT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283906","title":"Niagen Bioscience Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283906","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283906?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:15","pubTimestamp":1778498100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 07:15 ET (11:15 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633721456","title":"Niagen Bioscience to attend Sohn Investment Conference Emerging Company Pavilion","url":"https://stock-news.laohu8.com/highlight/detail?id=2633721456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633721456?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:32","pubTimestamp":1778243540,"startTime":"0","endTime":"0","summary":"Niagen Bioscience management scheduled to attend two investor conferences in New York in May 2026.Participation set for May 12 at Sohn Investment Conference, with CFO Ozan Pamir representing company.CEO Rob Fried slated to join CFO Ozan Pamir for investor meetings at Benchmark Consumer One-On-One Conference on May 19.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL3xW2y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633302172","title":"The Benchmark Company Announces 4th Annual Consumer One-on-One Conference in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2633302172","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633302172?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:10","pubTimestamp":1778184600,"startTime":"0","endTime":"0","summary":"NEW YORK, May  07, 2026 (GLOBE NEWSWIRE) -- The Benchmark Company, a subsidiary of StoneX Group Inc. (“StoneX”; NASDAQ: SNEX), is pleased to announce its 4TH Annual Consumer One-on-One Conference at t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290609/11961/en/The-Benchmark-Company-Announces-4th-Annual-Consumer-One-on-One-Conference-in-New-York-City.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4517","FRPT","BK4121","LU0757428866.USD","LU2065731478.USD","KRUS","LU1878469433.USD","BK4142","JJSF","LU1169589451.USD","BK4127","BK4585","PATK","CALM","SNEX","BK4190","LU0054578231.USD","BK4211","LU0266013472.USD","SAH","BJRI","BK4212","CHEF","LU2065732104.USD","LU0053671581.USD","ONEW","FWRG","WEST","LU0128526141.USD","LU0029874061.USD","BK4124","BK4209","BK4102","NAGE","MBUU","LU1941712348.USD","DIN","LU1815336091.USD","CHCO","STKS","LU1941712264.USD","LIND","BK4588","ANDE","LU1169590202.USD","BK4214","PAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633317128","title":"Niagen Bioscience price target lowered to $12 from $13 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633317128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633317128?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:07","pubTimestamp":1778184458,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on Niagen Bioscience (NAGE) to $12 from $13 and keeps a Buy rating on the shares. The company’s Q1 res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-12-from-13-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-12-from-13-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633667261","title":"Niagen Bioscience posts investor deck outlining NAD+ healthy-aging strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2633667261","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633667261?lang=en_us&edition=fundamental","pubTime":"2026-05-07 07:39","pubTimestamp":1778110749,"startTime":"0","endTime":"0","summary":"Niagen Bioscience investor presentation outlined strategy to expand NAD+ franchise across consumer supplements, IV therapies, injections, skincare.Q1 2026 LTM metrics showed USD 130.4 million revenue, USD 18.6 million net income, USD 66.5 million cash, no debt.Niagen IV and injectables push targeted NAD+ IV market sized at about USD 300 million, positioned as faster to administer with fewer side effects versus NAD+ IV.Early traction cited for Niagen IV, including more than 1,500 clinics onboarded since August 2024, USD 6.4 million ingredient sales since launch.Product development highlighted Niagen NanoCloud topical format, positioned as waterless delivery to reduce degradation risk seen in water-based NAD+ skincare.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL9QdTdZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633168760","title":"Niagen Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633168760","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633168760?lang=en_us&edition=fundamental","pubTime":"2026-05-07 05:39","pubTimestamp":1778103551,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc reports results for the quarter ended March 31 - Earnings SummaryNiagen Bioscience Inc NAGE.OQ reported quarterly adjusted earnings of 7 cents per share for the quarter ended Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J3O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633590461","title":"Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590461","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633590461?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:07","pubTimestamp":1778098038,"startTime":"0","endTime":"0","summary":"Niagen Bioscience reaffirms 2026 sales outlook after first-quarter revenue and profit rose alongside investments in injections and skincare.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/biotech/26/05/52342938/niagen-bioscience-keeps-full-year-sales-forecast-intact-as-q1-revenue-profit-climbs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.niagenplus.com","stockEarnings":[{"period":"1week","weight":-0.0312},{"period":"1month","weight":-0.0683},{"period":"3month","weight":-0.2489},{"period":"6month","weight":-0.4841},{"period":"1year","weight":-0.7463},{"period":"ytd","weight":-0.4638}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.1396},{"period":"6month","weight":0.0782},{"period":"1year","weight":0.2526},{"period":"ytd","weight":0.0916}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.045249},{"month":2,"riseRate":0.5,"avgChangeRate":0.181088},{"month":3,"riseRate":0.3,"avgChangeRate":0.049759},{"month":4,"riseRate":0.6,"avgChangeRate":0.039691},{"month":5,"riseRate":0.454545,"avgChangeRate":0.002402},{"month":6,"riseRate":0.545455,"avgChangeRate":0.05145},{"month":7,"riseRate":0.5,"avgChangeRate":-0.007412},{"month":8,"riseRate":0.3,"avgChangeRate":-0.041379},{"month":9,"riseRate":0.3,"avgChangeRate":-0.054309},{"month":10,"riseRate":0.2,"avgChangeRate":-0.056092},{"month":11,"riseRate":0.7,"avgChangeRate":0.200397},{"month":12,"riseRate":0.3,"avgChangeRate":-0.024057}],"exchange":"NASDAQ","name":"Niagen Bioscience","nameEN":"Niagen Bioscience"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Niagen Bioscience(NAGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Niagen Bioscience,NAGE,Niagen Bioscience股票,Niagen Bioscience股票老虎,Niagen Bioscience股票老虎国际,Niagen Bioscience行情,Niagen Bioscience股票行情,Niagen Bioscience股价,Niagen Bioscience股市,Niagen Bioscience股票价格,Niagen Bioscience股票交易,Niagen Bioscience股票购买,Niagen Bioscience股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Niagen Bioscience(NAGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction